Homburger has advised CDR-Life AG. CDR-Life AG and Boehringer Ingelheim have entered into a new global licensing agreement focused on the development of CDR-Life’s innovative antibody-based...
CDR-Life Grants Global License to Boehringer Ingelheim for Autoimmune Therapy Development
CDR-Life Inc’s $76 Million Series A Financing Round
Homburger advised CDR-Life in the transaction. CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing...


























